NZ Hepatitis Research Review Issue 17

In this issue:

Ledipasvir-sofosbuvir effective and safe in HCV G1 cirrhosis
Using telbivudine + PegIFN in chronic HBV
Oral ledipasvir + sofosbuvir in HCV G1 and HIV co-infection
Tenofovir alafenamide looks promising in hepatitis B
Grazoprevir + elbasvir: high SVR rates in HCV G1
Hepatitis E vaccine well tolerated and immunogenic
Sofosbuvir + ribavirin prevents post-transplant HCV recurrence
Describing horizontally acquired HBV in NZ Māori

Please login below to download this issue (PDF)